MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

COVID-19

Selected References:

  • Allotey J, et al. 2020. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370:m3320.
  • American Society of Hematology. 2022. COVID-19 and VTE/anticoagulation: frequently asked questions. Available at URL: https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
  • Angelidou A, et al. 2021. Association of maternal perinatal SARS-CoV-2 infection with neonatal outcomes during the COVID-19 pandemic in Massachusetts. JAMA Netw Open Apr 1;4(4):e217523.
  • Auger N, et al. Congenital anomalies during Covid-19: artifact of surveillance or a real TORCH? Eur J Epidemiol. 39(6):613-621.
  • Carlson J, et al. Pre-Delta, Delta, and Omicron periods of the Coronavirus Disease 2019 (COVID-19) pandemic and health outcomes during delivery hospitalization. Obstet Gynecol. 143(1):131-138.
  • Chambers, et al. 2020. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA 324(13):1347-1348.
  • Che BW, et al. Effects of mild/asymptomatic COVID-19 on semen parameters and sex-related hormone levels in men: a systematic review and meta-analysis. Asian J Androl. 25(3):382-388.
  • Chen H, et al. 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395(10226):809-815.
  • Delahoy MJ, et al. 2020. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1347–1354.
  • DeSisto C, et al. 2021. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization – United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep 2021;70:1640–1645.
  • Edlow AG, et al. 2022. Neurodevelopmental outcomes at 1 year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy. JAMA Netw Open 5(6):e2215787.
  • Edlow AG, et al. 2023. Sex-specific neurodevelopmental outcomes among offspring of mothers with SARS-CoV-2 infection during pregnancy. JAMA Netw Open. 1;6(3):e234415.
  • Ellington S, et al. 2020. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69:769–775.
  • Engjom HM, et al. 2024. Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study. Nat Commun. 15;15(1):3234.
  • Fajardo-Martinez V, et al. 2024. Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero. Sci Rep. 24;14(1):11851.
  • Firestein MR, et al. 2023. Assessment of neurodevelopment in infants with and without exposure to asymptomatic or mild maternal SARS-CoV-2 infection during pregnancy. JAMA Netw Open. 6(4):e237396.
  • Galang RR, et al. 2021. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021. Clin Infect Dis May 22:ciab432.
  • Gilbert G.G. et al. 2021. Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test. Fertility and Sterility 117(2):287-296.
  • Gulersen M, et al. 2020. Clinical implications of SARS-CoV-2 infection in the viable preterm period. Am J Perinatol 37(11): 1077-1083.
  • Gurol-Urganci I, et al. 2021. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol May 20:S0002-9378(21)00565-2.
  • Harel L, et al. 2021. Does the presence of symptoms affect pregnancy outcomes in third trimester in women with SARS-CoV-2. The Journal of Maternal-Fetal & Neonatal Medicine. 35(25):7582–7589.
  • Hernández-Díaz S, et al. 2022. First trimester COVID-19 and the risk of major congenital malformations–international registry of coronavirus exposure in pregnancy. Birth Defects Res 1;114(15):906-914.
  • Holtmann N, et al. 2020. Assessment of SARS-CoV-2 in human semen – a cohort study. Fertility and Sterility 114 (2):233-238.
  • Huynh A, et al. 2022. SARS-CoV-2 placentitis and intraparenchymal thrombohematomas among COVID-19 infections in pregnancy. JAMA Netw Open 5(3):e225345.
  • Jaswa EG, et al. 2024. In utero exposure to maternal COVID-19 and offspring neurodevelopment through age 24 months. JAMA Netw Open. 7(10):e2439792.
  • Jering K, et al. 2021. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med 181(5):714-717.
  • Karasek D, et al. 2021. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California. The Lancet Regional Health – Americas Volume 2. DOI: https://doi.org/10.1016/j.lana.2021.100027
  • Khoury R, et al. 2020. MD Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers. Obstetrics & Gynecology 136(2):273-282.
  • Krogstad P, et al. 2022. No infectious SARS-CoV-2 in breast milk from a cohort of 110 lactating women. Pediatr Res. Published online January 19, 2022. DOI: https://doi.org/10.1038/s41390-021-01902-y
  • Kummer J, et al. 2024. Covid-19 during pregnancy – Histopathological lesions of the placenta. Z Geburtshilfe Neonatol. 228(1):49-56.
  • Lai J, et al. 2021. SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality. AJOG 225(6):689-693.e1.
  • Lau M, 2023. Observational study on the neonatal outcome during the COVID-19 pandemic in Germany. Acta Paediatr. 112(9):1892-1897.
  • Li Y, et al. 2020. Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis 26(6):1335-1336.
  • Ludvigsson JF, et al. 2024. Three Scandinavian countries did not see the same increase in foetal situs inversus observed in China during the COVID-19 pandemic. Acta Paediatr. 113(4):751-752.
  • Maeda MFY, et al. 2021. Vertical transmission of SARS-CoV2 during pregnancy: a high-risk cohort. Prenat Diag Jul;41(8):998-1008.
  • Magnus MC, et al. 2024. Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study. BMJ. 386:e079364.
  • Metz TD, et al. 2022. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA 327(8):748-759.
  • Neelam V, et al. 2022. Pregnancy and infant outcomes by trimester of SARS-CoV-2 infection in pregnancy – SET-NET, 22 jurisdictions, January 25, 2020 - December 31, 2020. Birth Defects Research, 1– 15.
  • Newton SM, et al. Preterm birth among pregnant persons with severe acute respiratory syndrome Coronavirus 2 infection. J Perinatol 42:1328–1337.
  • Norman M, et al. 2021. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA May 25;325(20):2076-2086.
  • Piekos SN, et al. 2022. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet 4(2):E95-E104.
  • Reeves EL, et al. 2024. Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance – Surveillance for Emerging Threats to Pregnant People and Infants. Am J Obstet Gynecol MFM. 6(2):101265.
  • Ren H, et al. 2024. The association of increased incidence of congenital heart disease in newborns with maternal COVID-19 infection during pregnancy. Sci Rep. 22;14(1):24866.
  • Rosen H, et al. 2021. Fetal and perinatal outcome following first and second trimester COVID-19 infection: evidence from a prospective cohort study. J Clin Med May 16;10(10):2152.
  • Salvatore CM, et al. 2020. Neonatal management and outcomes during the COIVD-19 pandemic: an observation cohort study. Lancet Child & Adol Health 4(10):721-727.
  • Santos CAD, et al. 2024. Developmental impairment in children exposed during pregnancy to maternal SARS-COV2: A Brazilian cohort study. Int J Infect Dis. 139:146-152.
  • Sardinha TG, et al. 2024. The effect of body mass index on maternal and perinatal outcomes in COVID-19 infection during pregnancy and postpartum: Secondary analysis from the REBRACO cohort study. Int J Gynaecol Obstet. 164(3):1019-1027.
  • Scalia B, et al. 2024. Cranial ultrasonographic findings in newborns exposed to SARS-CoV-2: a single-centre cross-sectional analysis. Ital J Pediatr. 5;50(1):257.
  • Schulte A, et al. 2024. COVID-19 in pregnancy: prevalence, management, and outcomes in a single large health system. J Matern Fetal Neonatal Med. 37(1):2409360.
  • Shlomai NO, et al. 2021. Neonatal SARS-CoV-2 infections in breastfeeding mothers. Pediatrics May;147(5):e2020010918.
  • Shuffrey LC, et al. 2021. Association of birth during the COVID-19 pandemic with neurodevelopmental status at 6 months in infants with and without in utero exposure to maternal SARS-CoV-2 infection. JAMA Pediatr 176(6):e215563.
  • Smith ER, et al. 2023. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health 8(1):e009495.
  • Stock S, et al. 2022. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nat Med 28, 504–512.
  • van Baar JAC, et al: PregCOV-19 Living Systematic Review Consortium. 2024. COVID-19 in pregnant women: a systematic review and meta-analysis on the risk and prevalence of pregnancy loss. Hum Reprod Update. 1;30(2):133-152.
  • Villar J, et al. 2021. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr Apr 22:e211050.
  • Vivanti AJ, et al. 2020. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 11, 
  • Wei SQ, et al. 2021. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ Apr 19;193(16):E540-E548.
  • Wang Y, et al. 2023. Association of SARS-CoV-2 infection during early weeks of gestation with situs inversus. N Engl J Med. 2;389(18):1722-1724.
  • Wesselink A, et al. 2022. A prospective cohort study of COVID-19 vaccination, SARS-CoV-2 infection, and fertility. American Journal of Epidemiology 191(8):1383–1395.
  • Wong YP, et al. 2021. The effects of COVID-19 on placenta and pregnancy: what do we know so far? Diagnostics (Basel) Jan 8;11(1):94.
  • Zambrano LD, et al. 2020. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep 69:769–75.
  • Zeng L, et al. 2020. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 174(7):722-725.
  • Zhou SM, et al. 2024. COVID-19 and pregnancy: a comprehensive study of comorbidities and outcomes. BMC Public Health. 24(1):3157.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.